Generation of a bioactive neuropeptide in a cell-free system

Analytical Biochemistry

Volumn 316, Issue 1, 2003, Pages 34-40

  Jiang, Cecilia ^a   Chen, Guifen ^b   Zeng, Xuemei ^b   Ouyang, Keqing ^c   Hu, Yinghe ^b  

^a GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

^b EAST CHINA NORMAL UNIVERSITY   (China)

^c CHONGQING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; PEPTIDES; TRANSCRIPTION;

BIOACTIVE PEPTIDES; CELL EXTRACTS; CELL-FREE SYSTEM; FUNCTIONAL ASSAYS; G PROTEIN COUPLED RECEPTORS; IN-VITRO ASSAYS; REPORTER GENE ASSAYS; SYNTHESIS AND PROCESSING;

CLONING;

ALPHA INTERMEDIN; CELL EXTRACT; COMPLEMENTARY DNA; MELANOCORTIN 4 RECEPTOR; NEUROPEPTIDE; PEPTIDE; PROOPIOMELANOCORTIN;

ANIMAL CELL; ARTICLE; CELL FREE SYSTEM; CELL LINE; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HYPOPHYSIS CELL; IN VITRO STUDY; MOLECULAR CLONING; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; RAT; SYNTHESIS; TRANSCRIPTION INITIATION; TRANSLATION INITIATION;

EID: 0037402237     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-2697(03)00040-X     Document Type: Article

References (41)

1. Beinfeld M.C. Prohormone and proneuropeptide processing. Recent progress and future challenges. Endocrine. 8:1998;1-5.
2. Steiner D.F. The proprotein convertases. Curr. Opin. Chem. Biol. 2:1998;31-39.
3. Castro M.G., Morrison E. Post-translational processing of proopiomelanocortin in the pituitary and in the brain. Crit. Rev. Neurobiol. 11:1997;35-57.
4. Pritchard L.E., Turnbull A.V., White A. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J. Endocrinol. 172:2002;411-421.
5. Solomon S. POMC-derived peptides and their biological action. Ann. N.Y. Acad. Sci. 885:1999;22-40.
6. Sautel M., Milligan G. Molecular manipulation of G-protein-coupled receptors: a new avenue into drug discovery. Curr. Med. Chem. 7:2000;889-896.
7. Sadee W., Hoeg E., Lucas J., Wang D. Genetic variations in human G protein-coupled receptors: implications for drug therapy. AAPS Pharm. Sci. 2001;3.
8. Wilson S., Bergsma D.J., Chambers J.K., Muir A.I., Fantom K.G., Ellis C., Murdock P.R., Herrity N.C., Stadel J.M. Orphan G-protein-coupled receptors: the next generation of drug targets? Br. J. Pharmacol. 125:1998;1387-1392.
9. Gurrath M. Peptide-binding G protein-coupled receptors: new opportunities for drug design. Curr. Med. Chem. 8:2001;1605-1648.
10. Levchenko M.E., Katayama T., Kanehisa M. Discovery and classification of peptide family G-protein coupled receptors in the human genome sequence. Genome Informatics. 12:2001;352-353.
11. Fitzgerald L.R., Mannan I.J., Dytko G.M., Wu H.L., Nambi P. Measurement of responses from Gi-, Gs-, or Gq-coupled receptors by a multiple response element/cAMP response element-directed reporter assay. Anal. Biochem. 275:1999;54-61.
12. Treisman R. Journey to the surface of the cell: Fos regulation and the SRE. EMBO J. 14:1995;4905-4913.
13. Marshall G.R. Peptide interactions with G-protein coupled receptors. Biopolymers. 60:2001;246-277.
14. Marinissen M.J., Gutkind J.S. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol. Sci. 22:2001;368-376.
15. Bockaert J., Pin J.P. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 18:1999;1723-1729.
16. Wess J. G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J. 11:1997;346-354.
17. Shenker A. G protein-coupled receptor structure and function: the impact of disease-causing mutations. Baillieres Clin. Endocrinol. Metab. 9:1995;427-451.
18. Le Poul E., Hisada S., Mizuguchi Y., Dupriez V.J., Burgeon E., Detheux M. Adaptation of aequorin functional assay to high throughput screening. J. Biomol. Screen. 7:2002;57-65.
19. Kotani M., Mollereau C., Detheux M., Le Poul E., Brezillon S., Vakili J., Mazarguil H., Vassart G., Zajac J.M., Parmentier M. Functional characterization of a human receptor for neuropeptide FF and related peptides. Br. J. Pharmacol. 133:2001;138-144.
20. Milligan G., Rees S. Chimaeric G alpha proteins: their potential use in drug discovery. Trends Pharmacol. Sci. 20:1999;118-124.
21. Xing H., Tran H.C., Knapp T.E., Negulescu P.A., Pollok B.A. A fluorescent reporter assay for the detection of ligands acting through Gi protein-coupled receptors. J. Recept. Signal. Transduct. Res. 20:2000;189-210.
22. Saunders S.E., Burke J.F., Benjamin P.R. Multimeric CREB-binding sites in the promoter regions of a family of G-protein-coupled receptors related to the vertebrate galanin and nociceptin/orphanin-FQ receptor families. Eur. J. Neurosci. 12:2000;2345-2353.
23. Sklar L.A., Vilven J., Lynam E., Neldon D., Bennett T.A., Prossnitz E. Solubilization and display of G protein-coupled receptors on beads for real-time fluorescence and flow cytometric analysis. Biotechniques. 28:2000;976-980. 982-985.
24. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 92:1998;573-585.
25. Kojima M., Hosoda H., Kangawa K. Purification and distribution of ghrelin: the natural endogenous ligand for the growth hormone secretagogue receptor. Horm. Res. 56:2001;93-97.
26. Howard A.D., McAllister G., Feighner S.D., Liu Q., Nargund R.P., Van der Ploeg L.H., Patchett A.A. Orphan G-protein-coupled receptors and natural ligand discovery. Trends Pharmacol. Sci. 22:2001;132-140.
27. Kojima M., Haruno R., Nakazato M., Date Y., Murakami N., Hanada R., Matsuo H., Kangawa K. Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3). Biochem. Biophys. Res. Commun. 276:2000;435-438.
28. Reinscheid R.K., Nothacker H.P., Civelli O. Orphan receptors and the concept of reverse physiology: discovery of the novel neuropeptide orphanin FQ/nociceptin. Results Probl. Cell Differ. 26:1999;193-214.
29. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J. Jr., Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science. 270:1995;792-794.
30. Xu H., Shields D. Prohormone processing in the trans-Golgi network: endoproteolytic cleavage of prosomatostatin and formation of nascent secretory vesicles in permeabilized cells. J. Cell Biol. 122:1993;1169-1184.
31. Mzhavia N., Qian Y., Feng Y., Che F.Y., Devi L.A., Fricker L.D. Processing of proSAAS in neuroendocrine cell lines. Biochem. J. 361:2002;67-76.
32. Fortenberry Y., Hwang J.R., Apletalina E.V., Lindberg I. Functional characterization of ProSAAS: similarities and differences with 7B2. J. Biol. Chem. 277:2002;5175-5186.
33. Schaner P., Todd R.B., Seidah N.G., Nillni E.A. Processing of prothyrotropin-releasing hormone by the family of prohormone convertases. J. Biol. Chem. 272:1997;19958-19968.
34. Hook V.Y., Schiller M.R., Nguyen C., Yasothornsrikul S. Production of radiolabeled neuropeptide precursors by in vitro transcription and translation. Pept. Res. 9:1996;183-187.
35. Friedman T.C., Loh Y.P., Cawley N.X., Birch N.P., Huang S.S., Jackson I.M., Nillni E.A. Processing of prothyrotropin-releasing hormone (Pro-TRH) by bovine intermediate lobe secretory vesicle membrane PC1 and PC2 enzymes. Endocrinology. 136:1995;4462-4472.
36. Jegou S., Tranchand-Bunel D., Delbende C., Blasquez C., Vaudry H. Characterization of alpha-MSH-related peptides released from rat hypothalamic neurons in vitro. Brain Res. Mol. Brain Res. 5:1989;219-226.
37. Nillni E.A., Steinmetz R., Pescovitz O.H. Posttranslational processing of progrowth hormone-releasing hormone. Endocrinology. 140:1999;5817-5827.
38. Montuenga L.M., Burrell M.A., Garayoa M., Llopiz D., Vos M., Moody T., Garcia-Ros D., Martinez A., Villaro A.C., Elsasser T., Cuttitta F. Expression of proadrenomedullin derived peptides in the mammalian pituitary: co-localization of follicle stimulating hormone and proadrenomedullin N-20 terminal peptide-like peptide in the same secretory granules of the gonadotropes. J. Neuroendocrinol. 12:2000;607-617.
39. Benjannet S., Lusson J., Hamelin J., Savaria D., Chretien M., Seidah N.G. Structure-function studies on the biosynthesis and bioactivity of the precursor convertase PC2 and the formation of the PC2/7B2 complex. FEBS Lett. 362:1995;151-155.
40. Callard G.V., Petro Z., Tashjian A.H. Jr. Identification of aromatase activity in rodent pituitary cell strains. Endocrinology. 113:1983;152-158.
41. Bergeron F., Sirois F., Mbikay M. ACTH secretion by mouse corticotroph AtT20 cells is negatively modulated by the intracellular level of 7B2. FEBS Lett. 512:2002;259-262.